CAS: 1609392-27-9
Tyk2-IN-4
CAS:1609392-27-9
Formula:
C20H19D3N8O3
Purity:
99%
Color and Shape:
Solid
Molecular weight:
425.4590
Ref: IN-DA01EO63
| 1g | 183.00 € | ||
| 5g | 639.00 € | ||
| 10g | To inquire | ||
| 25g | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-B-210001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Deucravacitinib
CAS:1609392-27-9
Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable, allosteric TYK2 inhibitor.Cost-effective and quality-assured.
Formula:
C20H19D3N8O3
Purity:
100% - 99.43%
Color and Shape:
Solid
Molecular weight:
425.46
Ref: TM-T14687
| 1mg | 69.00 € | ||
| 5mg | 149.00 € | ||
| 10mg | 269.00 € | ||
| 25mg | 425.00 € | ||
| 50mg | 625.00 € | ||
| 100mg | 892.00 € | ||
| 200mg | 1,205.00 € | ||
| 500mg | 1,784.00 € | ||
| 1mL*10mM (DMSO) | 165.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
Deucravacitinib
Controlled ProductCAS:1609392-27-9
Formula:
C20D3H19N8O3
Color and Shape:
Neat
Molecular weight:
425.459
Ref: TR-D665481
| 250mg | 9,139.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
BMS-986165
CAS:1609392-27-9
BMS-986165 is a P-glycoprotein (P-gp) inhibitor that has been shown to reduce the absorption of …
Formula:
C20H19D3N8O3
Purity:
Min. 95%
Molecular weight:
425.46 g/mol
Ref: 3D-JPC39227
| 25mg | 356.00 € | ||
| 250mg | 1,334.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
